다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of clinical medicine, v.8 no.8, 2019년, pp.1227 -
Kuo, Yu-Kai (School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan) , Lin, I-Chan (Department of Ophthalmology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan) , Chien, Li-Nien (School of Health Care Administration, College of Management, , Taipei Medical University, Taipei 11031, Taiwan) , Lin, Tzu-Yu (Department of Ophthalmology, Shuang Ho Hospital, Taipei Medical University, New Taipei City 23561, Taiwan) , How, Ying-Ting (Graduate Institute of Biomedical Materials & Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan) , Chen, Ko-Hua (Department of Ophthalmology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan) , Dusting, Gregory J. (Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia) , Tseng, Ching-Li (Graduate Institute of Biomedical Materials & Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei 11031, Taiwan)
AI-Helper
Dry eye disease (DED) has become common on a global scale in recent years. There is a wide prevalence of DED in different countries based on various ethnicities and environment. DED is a multifactorial ocular disorder. In addition to advanced age and gender, such factors as living at high altitude, ...
Collum Dry eye: Diagnosis and current treatment strategies Curr. Allergy Asthma Rep. 2004 10.1007/s11882-004-0077-2 4 314
Craig TFOS DEWS II Definition and Classification Report Ocul. Surf. 2017 10.1016/j.jtos.2017.05.008 15 276
10.1016/S1542-0124(12)70081-2 (2007). The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul. Surf., 5, 75-92.
Messmer The pathophysiology, diagnosis and treatment of dry eye disease Dtsch. Arztebl. Int. 2015 112 71
Bron Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests Cornea 2003 10.1097/00003226-200310000-00008 22 640
Miller Minimal clinically important difference for the ocular surface disease index Arch. Ophthalmol. (Chic. ILL. 1960) 2010 10.1001/archophthalmol.2009.356 128 94
Yeh Concordance between patient and clinician assessment of dry eye severity and treatment response in Taiwan Cornea 2015 10.1097/ICO.0000000000000409 34 500
Henrich Association of dry eye and inflammatory systemic diseases in a tertiary care-based sample Cornea 2014 10.1097/ICO.0000000000000173 33 819
Stevens Schirmer’s test Community Eye Health 2011 24 45
Benelli Tear osmolarity measurement using the TearLab™ Osmolarity System in the assessment of dry eye treatment effectiveness Contact Lens Anterior Eye 2010 10.1016/j.clae.2010.01.003 33 61
Yokoi Classification of Fluorescein Breakup Patterns: A Novel Method of Differential Diagnosis for Dry Eye Am. J. Ophthalmol. 2017 10.1016/j.ajo.2017.05.022 180 72
Reuter Tear film breakup and structure studied by simultaneous video recording of fluorescence and tear film lipid layer images Investig. Ophthalmol. Vis. Sci. 2013 10.1167/iovs.13-11878 54 4900
10.1007/978-1-4615-5359-5 Sullivan, D.A., Dartt, D.A., and Meneray, M.A. (1998). Tear Film Interferometry as a Diagnostic Tool for Evaluating Normal and Dry-Eye Tear Film. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2: Basic Science and Clinical Relevance, Springer US.
Arita Tear Interferometric Patterns Reflect Clinical Tear Dynamics in Dry Eye Patients Investig. Ophthalmol. Vis. Sci. 2016 10.1167/iovs.16-19788 57 3928
Tomlinson The international workshop on meibomian gland dysfunction: Report of the diagnosis subcommittee Investig. Ophthalmol. Vis. Sci. 2011 10.1167/iovs.10-6997f 52 2006
Messmer Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay Ophthalmology 2016 10.1016/j.ophtha.2016.07.028 123 2300
Strzemecka Extracellular MMP-9-Based Assessment of Ocular Surface Inflammation in Patients with Primary Open-Angle Glaucoma J. Ophthalmol. 2019 2019 1240537
Amparo Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry Eye Ophthalmology 2015 10.1016/j.ophtha.2015.02.037 122 1498
Simpson Dry eye symptoms assessed by four questionnaires Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 2008 10.1097/OPX.0b013e318181ae36 85 692
Chalmers Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) and opinion of contact lens performance Opt. Vis. Sci. Off. Publ. Am. Acad. Optom. 2012 89 1435
Pflugfelder Prevalence, burden and pharmacoeconomics of dry eye disease Am. J. Manag. Care 2008 14 S102
Patel Work productivity loss in patients with dry eye disease: An online survey Curr. Med. Res. Opin. 2011 10.1185/03007995.2011.566264 27 1041
Yu The economic burden of dry eye disease in the United States: A decision tree analysis Cornea 2011 10.1097/ICO.0b013e3181f7f363 30 379
Dalzell Dry eye: Prevalence, utilization and economic implications Manag. care (Langhorne Pa.) 2003 12 9
Farrand Prevalence of Diagnosed Dry Eye Disease in the United States Among Adults Aged 18 Years and Older Am. J. Ophthalmol. 2017 10.1016/j.ajo.2017.06.033 182 90
Gayton Etiology, prevalence and treatment of dry eye disease Clin. Ophthalmol. (Auckland N.Z.) 2009 10.2147/OPTH.S5555 3 405
Han Prevalence of dry eye disease in an elderly Korean population Arch. Ophthalmol. (Chicago ILL 1960) 2011 10.1001/archophthalmol.2011.78 129 633
Uchino Prevalence and risk factors of dry eye disease in Japan: Koumi study Ophthalmology 2011 10.1016/j.ophtha.2011.05.029 118 2361
Lin Prevalence of dry eye among an elderly Chinese population in Taiwan: The Shihpai Eye Study Ophthalmology 2003 10.1016/S0161-6420(03)00262-8 110 1096
Yen The Prevalence of Dry Eye Syndrome’s and the Likelihood to Develop Sjogren’s Syndrome in Taiwan: A Population-Based Study Int. J. Environ. Res. Public Health 2015 10.3390/ijerph120707647 12 7647
Hashemi Prevalence of dry eye syndrome in an adult population Clin. Exp. Ophthalmol. 2014 10.1111/ceo.12183 42 242
Lu Dry eye syndrome in elderly Tibetans at high altitude: A population-based study in China Cornea 2008 10.1097/ICO.0b013e318165b1b7 27 545
Bjerrum Keratoconjunctivitis sicca and primary Sjogren’s syndrome in a Danish population aged 30-60 years Acta Ophthalmol. Scand. 1997 10.1111/j.1600-0420.1997.tb00774.x 75 281
Mody Keratoconjunctivitis sicca in rheumatoid arthritis Clin. Rheumatol. 1988 10.1007/BF02204461 7 237
Lemp Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes CLAO J. Off. Publ. Contact Lens Assoc. Ophthalmol. 1995 21 221
Albietz Prevalence of dry eye subtypes in clinical optometry practice Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 2000 10.1097/00006324-200007000-00010 77 357
Chen Dry eye syndrome and the subsequent risk of chronic fatigue syndrome-a prospective population-based study in Taiwan Oncotarget 2018 10.18632/oncotarget.25544 9 30694
Qin Combination of recurrent oral aphthae and dry eye syndrome may constitute an independent risk factor for oral cavity cancer in elderly women Cancer Manag. Res. 2018 10.2147/CMAR.S168477 10 3273
10.3390/ijerph15102269 Zhong, J.Y., Lee, Y.C., Hsieh, C.J., Tseng, C.C., and Yiin, L.M. (2018). Association between Dry Eye Disease, Air Pollution and Weather Changes in Taiwan. Int. J. Environ. Res. Public Health, 15.
Chen Dry Eye Syndrome Risks in Patients With Fibromyalgia: A National Retrospective Cohort Study Medicine 2016 10.1097/MD.0000000000002607 95 e2607
Chen Association between Glaucoma Medication Usage and Dry Eye in Taiwan Opt. Vis. Sci. Off. Publ. Am. Acad. Opt. 2015 92 e227
Huang Association between dry eye disease and asthma: A nationwide population-based study Peer J. 2018 10.7717/peerj.5941 6 e5941
10.1371/journal.pone.0207008 Jeng, Y.T., Lin, S.Y., Hu, H.Y., Lee, O.K., and Kuo, L.L. (2018). Osteoporosis and dry eye syndrome: A previously unappreciated association that may alert active prevention of fall. PLoS ONE, 13.
10.3390/jcm8010062 Lee, C.Y., Chen, H.C., Sun, C.C., Lin, H.Y., Lu, K.H., Huang, J.Y., Yeh, C.B., and Yang, S.F. (2019). Gout as a Risk Factor for Dry Eye Disease: A Population-Based Cohort Study. J. Clin. Med., 8.
10.1007/s10792-019-01117-5 Mai, E.L.C., Lin, C.C., Lian, I., Liao, R., Chen, M., and Chang, C. (2019). Population-based study on the epidemiology of dry eye disease and its association with presbyopia and other risk factors. Int. Ophthalmol., 1-9.
10.1371/journal.pone.0201340 Chen, H.H., Chao, W.C., Liao, T.L., Lin, C.H., and Chen, D.Y. (2018). Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study. PLoS ONE, 13.
Guo Prevalence of dry eye disease in Mongolians at high altitude in China: The Henan eye study Ophthalmic Epidemiol. 2010 10.3109/09286586.2010.498659 17 234
Moss Prevalence of and risk factors for dry eye syndrome Arch. Ophthalmol. (Chic. Ill. 1960) 2000 10.1001/archopht.118.9.1264 118 1264
Paulsen Dry eye in the beaver dam offspring study: Prevalence, risk factors and health-related quality of life Am. J. Ophthalmol. 2014 10.1016/j.ajo.2013.12.023 157 799
Song Variations of dry eye disease prevalence by age, sex and geographic characteristics in China: A systematic review and meta-analysis J. Glob. Health 2018 10.7189/jogh.08.020503 8 020503
Clayton Dry Eye New Engl. J. Med. 2018 10.1056/NEJMra1407936 378 2212
McCulley Meibomian gland function and the tear lipid layer Ocul. Surf. 2003 10.1016/S1542-0124(12)70138-6 1 97
Georgiev Structure-function relationship of tear film lipid layer: A contemporary perspective Exp. Eye Res. 2017 10.1016/j.exer.2017.03.013 163 17
Sledge Evaporation and Hydrocarbon Chain Conformation of Surface Lipid Films Ocul. Surf. 2016 10.1016/j.jtos.2016.06.002 14 447
Georgiev Surface relaxations as a tool to distinguish the dynamic interfacial properties of films formed by normal and diseased meibomian lipids Soft Matter 2014 10.1039/C4SM00758A 10 5579
Butovich The international workshop on meibomian gland dysfunction: Report of the subcommittee on tear film lipids and lipid-protein interactions in health and disease Investig. ophthalmol. Vis. Sci. 2011 10.1167/iovs.10-6997d 52 1979
Fink The contribution of lipid layer movement to tear film thinning and breakup Investig. Ophthalmol. Vis. Sci. 2009 10.1167/iovs.08-2459 50 2747
Knop Meibomian glands. Part II: Physiology, characteristics, distribution and function of meibomian oil Der Ophthalmol. Z. Der Dtsch. Ophthalmol. Ges. 2009 106 884
Murube The origin of tears. III. The lipid component in the XIX and XX centuries Ocul. Surf. 2012 10.1016/j.jtos.2012.08.001 4 200
Conrady Review: The Lacrimal Gland and Its Role in Dry Eye J. Ophthalmol. 2016 10.1155/2016/7542929 2016 7542929
Dartt Complexity of the tear film: Importance in homeostasis and dysfunction during disease Exp. Eye Res. 2013 10.1016/j.exer.2013.10.008 117 1
Phadatare A Comprehensive Review on Dry Eye Disease: Diagnosis, Medical Management, Recent Developments and Future Challenges Adv. Pharm. 2015 2015 12
10.3390/ijms18071398 Zhang, X., Vimalin, M.J., Qu, Y., He, X., Ou, S., Bu, J., Jia, C., Wang, J., Wu, H., and Liu, Z. (2017). Dry Eye Management: Targeting the Ocular Surface Microenvironment. Int. J. Mol. Sci., 18.
Kunert Analysis of topical cyclosporine treatment of patients with dry eye syndrome: Effect on conjunctival lymphocytes Arch. Ophthalmol. (Chic. Ill. 1960) 2000 10.1001/archopht.118.11.1489 118 1489
Solomon Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease Investig. Ophthalmol. Vis. Sci. 2001 42 2283
Cejkova Nitric oxide synthase induction and cytotoxic nitrogen-related oxidant formation in conjunctival epithelium of dry eye (Sjogren’s syndrome) Nitric. Oxide Biol. Chem. 2007 10.1016/j.niox.2007.04.006 17 10
Hessen Dry eye: An inflammatory ocular disease J. Ophthalmic Vis.Res. 2014 9 240
Stern Conjunctival T-cell subpopulations in Sjogren’s and non-Sjogren’s patients with dry eye Investig. Ophthalmol. Vis. Sci. 2002 43 2609
Wei The core mechanism of dry eye disease is inflammation Eye Contact Lens 2014 10.1097/ICL.0000000000000042 40 248
Hom Prevalence of Meibomian gland dysfunction Optom. Vis. Sci. Off. Publ. Am. Acad Optom. 1990 10.1097/00006324-199009000-00010 67 710
Foulks Meibomian Gland Dysfunction: A Clinical Scheme for Description, Diagnosis, Classification and Grading Ocul. Surf. 2003 10.1016/S1542-0124(12)70139-8 1 107
Foulks The correlation between the tear film lipid layer and dry eye disease Surv. Ophthalmol. 2007 10.1016/j.survophthal.2007.04.009 52 369
Rege A Clinical Study of Subtype-based Prevalence of Dry Eye J. Clin. Diagn. Res. JCDR 2013 7 2207
Albietz Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction Clin. Exp. Optom. 2018 10.1111/cxo.12541 101 23
Blackie Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: A review Curr. Opin. Ophthalmol. 2015 10.1097/ICU.0000000000000165 26 306
Kim Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2017 10.1089/jop.2017.0019 33 635
Qiao Emerging treatment options for meibomian gland dysfunction Clin. Ophthalmol. (Auckl. N.Z.) 2013 7 1797
Zhao Clinical Trial of Thermal Pulsation (LipiFlow) in Meibomian Gland Dysfunction With Preteatment Meibography Eye Contact Lens 2016 10.1097/ICL.0000000000000228 42 339
Pang Efficacy of Vectored Thermal Pulsation and Warm Compress Treatments in Meibomian Gland Dysfunction: A Meta-Analysis of Randomized Controlled Trials Cornea 2019 10.1097/ICO.0000000000001907 39 690
Borchman The optimum temperature for the heat therapy for meibomian gland dysfunction Ocul. Surf. 2019 10.1016/j.jtos.2019.02.005 17 360
10.1371/journal.pone.0208420 Garcia, D.M., Reis de Oliveira, F., Módulo, C.M., Faustino, J., Barbosa, A.P., Alves, M., and Rocha, E.M. (2018). Is Sjögren’s syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests. PLoS ONE, 13.
Chen Discrimination between Sjögren’s and Non-Sjögren’s Sicca Syndrome by Sialoscintigraphy and Antibodies against α-Fodrin and Ro/La Autoantigens J. Int. Med. Res. 2009 10.1177/147323000903700413 37 1088
Fairchild Clinically important difference in dry eye: Change in IDEEL-symptom bother Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 2008 10.1097/OPX.0b013e3181824e0d 85 699
Javadi Dry eye syndrome J. Ophthalmic. Vis. Res. 2011 6 192
Christodoulou Characteristics of the minor salivary gland infiltrates in Sjogren’s syndrome J. Autoimmun. 2010 10.1016/j.jaut.2009.10.004 34 400
Coursey Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy Clin. Ophthalmol. (Auckl. N.Z.) 2014 8 1447
Dart Cicatricial pemphigoid and dry eye Semin. Ophthalmol. 2005 10.1080/08820530590931368 20 95
Salzano OC9 Successful use of mycophenolate mofetil in combination with minocycline in a woman with severe predominantly oral mucous membrane pemphigoid: A case report Oral. Dis. 2006 10.1111/j.1601-0825.2006.01308_9.x 12 11
McCluskey Methotrexate therapy for ocular cicatricial pemphigoid Ophthalmology 2004 10.1016/j.ophtha.2003.07.010 111 796
Neff Treatment strategies in mucous membrane pemphigoid Ther. Clin. Risk Manag. 2008 10.2147/TCRM.S1140 4 617
Heffernan Successful treatment of mucous membrane pemphigoid with infliximab Arch. Dermatol. 2006 10.1001/archderm.142.10.1268 142 1268
Foster Ocular cicatricial pemphigoid review Curr. Opin. Allergy Clin. Immunol. 2004 10.1097/00130832-200410000-00017 4 435
Donnenfeld Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid Ophthalmology 1999 10.1016/S0161-6420(99)90022-2 106 72
Juri Systemic treatment of ocular cicatricial pemphigoid Medicina 2012 72 103
Ma Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy Ocul. Immunol. Inflamm. 2018 10.1080/09273948.2018.1433302 27 636
Tsubota Surgical Reconstruction of the Ocular Surface in Advanced Ocular Cicatricial Pemphigoid and Stevens-Johnson Syndrome Am. J. Ophthalmol. 1996 10.1016/S0002-9394(14)71962-2 122 38
Baudouin Preservatives in eyedrops: The good, the bad and the ugly Prog. Retin. Eye Res. 2010 10.1016/j.preteyeres.2010.03.001 29 312
Fujishima Allergic conjunctivitis and dry eye Br. J. Ophthalmol. 1996 10.1136/bjo.80.11.994 80 994
Toda Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis Ophthalmology 1995 10.1016/S0161-6420(95)31024-X 102 302
Akil Dry Eye Syndrome and Allergic Conjunctivitis in the Pediatric Population Middle East Afr. J. Ophthalmol. 2015 10.4103/0974-9233.167814 22 467
Hom Allergic conjunctivitis and dry eye syndrome Ann. Allergy Asthma Immunol. Off. Publ. Am. College Allergy Asthma Immunol. 2012 10.1016/j.anai.2012.01.006 108 163
Cardona Blink rate, blink amplitude and tear film integrity during dynamic visual display terminal tasks Curr. Eye Res. 2011 10.3109/02713683.2010.544442 36 190
Himebaugh Blinking and tear break-up during four visual tasks Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 2009 10.1097/OPX.0b013e318194e962 86 E106
White Blink Patterns in Normal and Dry Eye Subjects; Beyond Blink Rate Investig. Ophthalmol. Vis. Sci. 2010 51 3366
10.4018/978-1-5225-0432-0 Ogata, T.A. (2016). Assessing the appeal power of narrative performance by using eyeblink synchronization among audience. Computational and Cognitive Approaches to Narratology, Information Science Reference (IGI Global).
Johnston The interblink interval in normal and dry eye subjects Clin. Ophthalmol. (Auckl. N.Z.) 2013 10.2147/OPTH.S39104 7 253
Ousler Blink patterns and lid-contact times in dry-eye and normal subjects Clin. Ophthalmol. (Auckl. N.Z.) 2014 10.2147/OPTH.S56783 8 869
Pult The relation between blinking and conjunctival folds and dry eye symptoms Optom. Vis. Sci. Off Publ. Am. Acad. Optom. 2013 10.1097/OPX.0000000000000029 90 1034
McMonnies Optimum dry eye classification using questionnaire responses Adv. Exp. Med. Biol. 1998 10.1007/978-1-4615-5359-5_117 438 835
Gilbert The eye signs of vitamin A deficiency Community Eye Health 2013 26 66
Sommer Treatment of corneal xerophthalmia with topical retinoic acid Am. J. Ophthalmol. 1983 10.1016/S0002-9394(14)78304-7 95 349
Ubels The efficacy of retinoic acid ointment for treatment of xerophthalmia and corneal epithelial wounds Curr. Eye Research 1985 10.3109/02713688509003350 4 1049
Hatchell Treatment of xerophthalmia with retinol, tretinoin and etretinate Arch. Ophthalmol. (Chic. Ill. 1960) 1984 10.1001/archopht.1984.01040030746036 102 926
Taylor Hygiene factors and increased risk of trachoma in central Tanzania Arch. Ophthalmol. (Chic. Ill. 1960) 1989 10.1001/archopht.1989.01070020903037 107 1821
Patel A study of prevalence of dry eye in relation to trachoma Indian J. Clin. Exp. Ophthalmol. 2017 3 342
Bowman Operational comparison of single-dose azithromycin and topical tetracycline for trachoma Investig. Ophthalmol. Vis. Sci. 2000 41 4074
Baudouin One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease Eur. J. Ophthalmol. 2017 10.5301/ejo.5001002 27 678
Park A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2017 10.1089/jop.2016.0086 33 66
Kim A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome Am. J. Ophthalmol. 2009 10.1016/j.ajo.2008.08.015 147 206
Essa Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms? Contact Lens Anterior Eye J. Br. Contact Lens Assoc. 2018 10.1016/j.clae.2017.07.007 41 60
Simmons Artificial Tear Use Improves Objective Signs and Visual Symptoms of Dry Eye Investig. Ophthalmol. Vis. Sci. 2009 50 4646
Lievens Evaluation of an enhanced viscosity artificial tear for moderate to severe dry eye disease: A multicenter, double-masked, randomized 30-day study Contact Lens Anterior Eye 2019 10.1016/j.clae.2018.12.003 42 443
Bosch A randomized multicenter study comparing seawater washes and carmellose artificial tears eyedrops in the treatment of dry eye syndrome Clin. Ophthalmol. 2019 10.2147/OPTH.S185409 13 483
Aragona Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye Br. J. Ophthalmol. 2002 10.1136/bjo.86.2.181 86 181
You Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2018 10.1089/jop.2018.0032 34 557
10.1371/journal.pone.0157982 Tseng, C.L., Hung, Y.J., Chen, Z.Y., Fang, H.W., and Chen, K.H. (2016). Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome. PLoS ONE, 11.
Li Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye Curr.Eye Res. 2014 10.3109/02713683.2014.884595 39 871
Delves, P.J. (1998). Cyclosporine. Encyclopedia of Immunology, Elsevier. [2nd ed.].
Wu, J.J., Feldman, S.R., and Lebwohl, M.G. (2016). Chapter 6-Cyclosporine. Therapy for Severe Psoriasis, Elsevier.
Kahn Correlation between dose and level of cyclosporine after orthotopic liver transplantation Transplant. Proc. 1989 21 2240
Canafax Cyclosporine immunosuppression Clin. Pharm. 1983 2 515
Rhee Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: A review of the literature Clin. Ophthalmol. 2017 10.2147/OPTH.S113437 11 1157
Kymionis Treatment of chronic dry eye: Focus on cyclosporine Clin. Ophthalmol. (Auckl. N.Z.) 2008 10.2147/OPTH.S1409 2 829
Schultz Safety and efficacy of cyclosporine in the treatment of chronic dry eye Ophthalmol. Eye Dis. 2014 10.4137/OED.S16067 6 37
Othman Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease Saudi J. Ophthalmol. 2018 10.1016/j.sjopt.2018.06.001 32 217
Yavuz An Overview on Dry Eye Treatment: Approaches for Cyclosporin A Delivery Sci. World J. 2012 10.1100/2012/194848 2012 11
Andrews Dosing algorithms for initiation of immunosuppressive drugs in solid organ transplant recipients Expert Opin. Drug Metab. Toxicol. 2015 10.1517/17425255.2015.1033397 11 921
Perry Topical 0.05% cyclosporin in the treatment of dry eye Expert Opin. Pharmacother. 2004 10.1517/14656566.5.10.2099 5 2099
Straub Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up Br. J. Ophthalmol. 2016 10.1136/bjophthalmol-2015-306930 100 1547
Herrygers Efficacy of cyclosporine A (Restasis) for the treatment of dry eye symptoms in the first 30 days of therapy Investig. Ophthalmol. Vis. Sci. 2005 46 2026
Dastjerdi High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen Cornea 2009 10.1097/ICO.0b013e3181a16472 28 1091
Su The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy Cornea 2011 10.1097/ICO.0b013e318206caee 30 1098
Parrilha Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits Arq. Bras. De Oftalmol. 2015 10.5935/0004-2749.20150078 78 295
Demiryay Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome Eye Contact Lens 2011 10.1097/ICL.0b013e31822563be 37 312
Sahli The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye Cornea 2010 10.1097/ICO.0b013e3181e7845b 29 1412
Toker Corneal and conjunctival sensitivity in patients with dry eye: The effect of topical cyclosporine therapy Cornea 2010 10.1097/ICO.0b013e3181acf68d 29 133
Wang Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease Bone marrow Transplant. 2008 10.1038/sj.bmt.1705900 41 293
Geerling Autologous serum eye drops for ocular surface disorders Br. J. Ophthalmol. 2004 10.1136/bjo.2004.044347 88 1467
Higuchi Autologous Serum and Serum Components Investig. Ophthalmol. Vis. Sci. 2018 10.1167/iovs.17-23760 59 Des121
Lekhanont Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery BioMed Res. Int. 2013 10.1155/2013/521315 2013 521315
Quinto Autologous serum for ocular surface diseases Arq. Bras. De Oftalmol. 2008 10.1590/S0004-27492008000700010 71 47
Pan Autologous serum eye drops for dry eye Cochrane Database Syst. Rev. 2013 8 Cd009327
Jehangir Comprehensive Review of the Literature on Existing Punctal Plugs for the Management of Dry Eye Disease J. Ophthalmol. 2016 10.1155/2016/9312340 2016 22
Ervin Punctal occlusion for dry eye syndrome: Summary of a Cochrane systematic review Br. J. Ophthalmol. 2019 10.1136/bjophthalmol-2018-313267 103 301
Balaram Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome Am. J. Ophthalmol. 2001 10.1016/S0002-9394(00)00620-6 131 30
Tai The clinical efficacy of silicone punctal plug therapy Cornea 2002 10.1097/00003226-200203000-00001 21 135
Ababneh Bilateral Simultaneous Pyogenic Granuloma After Perforated Punctal Plug Insertion Ophthalmic Plast. Reconstr. Surg. 2014 10.1097/IOP.0b013e3182a5ba6b 30 e113
Rumelt Silicone Punctal Plug Migration Resulting in Dacryocystitis and Canaliculitis Cornea 1997 10.1097/00003226-199705000-00022 16 377
Marcet Safety and Efficacy of Lacrimal Drainage System Plugs for Dry Eye Syndrome: A Report by the American Academy of Ophthalmology Ophthalmology 2015 10.1016/j.ophtha.2015.04.034 122 1681
Henriquez Meibomian glands and contact lens wear Br. J. Ophthalmol. 1981 10.1136/bjo.65.2.108 65 108
Paugh Meibomian therapy in problematic contact lens wear Optom. Vis. Sci. Off. Publ. Am. Acad. Optom. 1990 10.1097/00006324-199011000-00002 67 803
Olson Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction Eye Contact Lens 2003 10.1097/01.ICL.0000060998.20142.8D 29 96
Tan The effects of a hydrating mask compared to traditional warm compresses on tear film properties in meibomian gland dysfunction Contact Lens Anterior Eye J. Br. Contact Lens Assoc. 2018 10.1016/j.clae.2017.09.006 41 83
Arita Effects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients Sci. Rep. 2017 10.1038/srep45848 7 45848
Dikstein The influence of eyelid temperature on the delivery of meibomian oil Exp Eye Res. 2004 10.1016/S0014-4835(03)00197-0 78 367
Truscott Presbyopia and cataract: A question of heat and time Prog. Retin. Eye Res. 2010 10.1016/j.preteyeres.2010.05.002 29 487
Danjo Alteration of mucin in human conjunctival epithelia in dry eye Investig. Ophthalmol. Vis. Sci. 1998 39 2602
Gamache Corneal protection by the ocular mucin secretagogue 15(S)-HETE in a rabbit model of desiccation-induced corneal defect J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2002 10.1089/10807680260218515 18 349
Arakawa 15th anniversary of rebamipide: Looking ahead to the new mechanisms and new applications Dig. Dis. Sci. 2005 10.1007/s10620-005-2800-9 50 S3
Iijima Rebamipide, a cytoprotective drug, increases gastric mucus secretion in human: Evaluations with endoscopic gastrin test Dig. Dis. Sci. 2009 10.1007/s10620-008-0507-4 54 1500
Kashima Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: A critical appraisal Clin. Ophthalmol. 2014 10.2147/OPTH.S40798 8 1003
10.1186/s12886-015-0040-0 Ueda, K., Matsumiya, W., Otsuka, K., Maeda, Y., Nagai, T., and Nakamura, M. (2015). Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye. BMC Ophthalmol., 15.
Shrivastava Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes Oman J. Ophthalmol. 2018 10.4103/ojo.OJO_29_2017 11 207
Kinoshita Rebamipide (OPC-12759) in the treatment of dry eye: A randomized, double-masked, multicenter, placebo-controlled phase II study Ophthalmology 2012 10.1016/j.ophtha.2012.06.052 119 2471
Hori Secreted Mucins on the Ocular Surface Investig. Ophthalmol. Vis. Sci. 2018 10.1167/iovs.17-23623 59 Des151
Keating Diquafosol ophthalmic solution 3 %: A review of its use in dry eye Drugs 2015 10.1007/s40265-015-0409-7 75 911
Lau P2Y2 receptor agonists for the treatment of dry eye disease: a review Clin. Ophthalmol. (Auckl. N.Z.) 2014 8 327
Matsumoto Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: A Japanese phase 2 clinical trial Ophthalmology 2012 10.1016/j.ophtha.2012.04.010 119 1954
Corrales Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye Exp. Eye Res. 2006 10.1016/j.exer.2006.02.004 83 526
Pleyer Intraocular pressure effects of common topical steroids for post-cataract inflammation: Are they all the same? Ophthalmol. Ther. 2013 10.1007/s40123-013-0020-5 2 55
Cutolo The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome Ocul. Immunol. Inflamm. 2019 10.1080/09273948.2017.1341988 27 266
Yang A clinical study of the efficacy of topical corticosteroids on dry eye J. Zhejiang Univ. Sci. B 2006 10.1631/jzus.2006.B0675 7 675
Jung Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjogren’s Syndrome Chonnam Med. J. 2015 10.4068/cmj.2015.51.1.26 51 26
Villani Soft steroid topical treatment for moderate to severe dry eye: Pulse vs tapered therapy Investig. Ophthalmol. Vis. Sci. 2013 54 4321
Singla, S., Sarkar, L., and Joshi, M. Comparison of topical cyclosporine alone and topical loteprednol with cyclosporine in moderate dry eye in Indian population: A prospective study. Taiwan J. Ophthalmol., Available online: http://www.e-tjo.org/preprintarticle.asp?id=250866.
Chinnery Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: A pilot study Ophthalmic Physiol. Opt. J. Br. Coll. Ophthalmic Opt. (Optom.) 2017 10.1111/opo.12365 37 473
Schmidl A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2017 10.1089/jop.2016.0123 33 375
Steven Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease J. Ocul. Pharmacol. Ther. Off. J. Assoc. Ocul. Pharmacol. Ther. 2017 33 67
Toshida Efficacy and safety of retinol palmitate ophthalmic solution in the treatment of dry eye: A Japanese Phase II clinical trial Drug Des. Dev. Ther. 2017 10.2147/DDDT.S137825 11 1871
Wang Effect of the Meibomian Gland Squeezer for Treatment of Meibomian Gland Dysfunction Cornea 2018 10.1097/ICO.0000000000001682 37 1270
10.3390/nu11050942 Chi, S.C., Tuan, H.I., and Kang, Y.N. (2019). Effects of Polyunsaturated Fatty Acids on Nonspecific Typical Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients, 11.
Liu Influence of Omega 3 and 6 Fatty Acids on Human Meibomian Gland Epithelial Cells Cornea 2016 10.1097/ICO.0000000000000874 35 1122
Luxan Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction Clin. Ophthalmol. (Auckl. N.Z.) 2014 8 831
Asbell n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease New Engl. J. Med. 2018 10.1056/NEJMoa1709691 378 1681
Hongyok Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye Arch. Ophthalmol. (Chic. Ill. 1960) 2009 10.1001/archophthalmol.2009.52 127 525
Fischak Effect of Topically Administered Chitosan-N-acetylcysteine on Corneal Wound Healing in a Rabbit Model J. Ophthalmol. 2017 10.1155/2017/5192924 2017 5192924
Kim The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats Acta Ophthalmol. 2012 10.1111/j.1755-3768.2012.02496.x 90 e540
Odaka Efficacy of retinol palmitate eye drops for dry eye in rabbits with lacrimal gland resection Clin. Ophthalmol. (Auckl. N.Z.) 2012 6 1585
Kobayashi Effect of retinol palmitate as a treatment for dry eye: A cytological evaluation Ophthalmol. J. Int. D’ophtalmologie Int. J. Ophthalmol. Z. fur Augenheilkd. 1997 10.1159/000310829 211 358
Fan Pigment epithelium-derived factor peptide reverses mouse age-related meibomian gland atrophy Exp. Eye Res. 2019 10.1016/j.exer.2019.05.018 185 107678
Hu Effect of laser acupuncture on dry eye: A study protocol for a 2-center randomized controlled trial Medicine 2018 10.1097/MD.0000000000010875 97 e10875
Wang Comparison effects of acupuncture at distal acupoints and local acupoints on treatment of xerophthalmia Zhongguo Zhen Jiu Chin. Acupunct. Moxibustion 2017 37 1069
Zhang Efficacy and safety of acupuncture at a single BL1 acupoint in the treatment of moderate to severe dry eye disease: Protocol for a randomized, controlled trial Medicine 2018 10.1097/MD.0000000000010924 97 e10924
Turman Safety and Efficacy Clinical Trials for SYL1001, a Novel Short Interfering RNA for the Treatment of Dry Eye Disease Investig. Ophthalmol. Vis. Sci. 2016 10.1167/iovs.16-20303 57 6447
Szallasi The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept Nat. Rev. Drug Discov. 2007 10.1038/nrd2280 6 357
Chang New Combination/Application of Polymer-Based Nanoparticles for Biomedical Engineering Adv. Exp. Med. Biol. 2018 10.1007/978-981-13-0950-2_14 1078 271
Huang Gelatin-epigallocatechin gallate nanoparticles with hyaluronic acid decoration as eye drops can treat rabbit dry-eye syndrome effectively via inflammatory relief Int. J. Nanomed. 2018 10.2147/IJN.S173198 13 7251
Liu Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome Nano Res. 2015 10.1007/s12274-014-0547-3 8 621
Zorzi A nanomedicine to treat ocular surface inflammation: Performance on an experimental dry eye murine model Gene Ther. 2012 20 467
Li Synergistically dual-functional nano eye-drops for simultaneous anti-inflammatory and anti-oxidative treatment of dry eye disease Nanoscale 2019 10.1039/C9NR00376B 11 5580
Vickers The Future of Dry Eye Treatment: A Glance into the Therapeutic Pipeline Ophthalmol. Ther. 2015 10.1007/s40123-015-0038-y 4 69
Luo Epigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye Syndrome Sci. Rep. 2017 10.1038/s41598-017-09913-8 7 9380
Wagh Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies J. Nanotechnol. 2014 10.1155/2014/683153 2014 10
Yu Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: Formulation, in vitro and in vivo studies Drug Deliv. 2018 10.1080/10717544.2018.1458923 25 888
Valamanesh A novel cyclosporin a aqueous formulation for dry eye treatment: In vitro and in vivo evaluation Investig. Ophthalmol. Vis. Sci. 2012 10.1167/iovs.11-8829 53 2292
Acar Novel liposome-based and in situ gelling artificial tear formulation for dry eye disease treatment Contact Lens Anterior Eye J. Br. Contact Lens Assoc. 2018 10.1016/j.clae.2017.11.004 41 93
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.